LNSR vs. MODD, CODX, CTCX, ICU, RVP, AKLI, FEMY, GBS, NMTC, and MDAI
Should you be buying LENSAR stock or one of its competitors? The main competitors of LENSAR include Modular Medical (MODD), Co-Diagnostics (CODX), Carmell (CTCX), SeaStar Medical (ICU), Retractable Technologies (RVP), Akili (AKLI), Femasys (FEMY), GBS (GBS), NeuroOne Medical Technologies (NMTC), and Spectral AI (MDAI). These companies are all part of the "surgical & medical instruments" industry.
Modular Medical (NASDAQ:MODD) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, community ranking, earnings and institutional ownership.
LENSAR received 3 more outperform votes than Modular Medical when rated by MarketBeat users. However, 100.00% of users gave Modular Medical an outperform vote while only 38.46% of users gave LENSAR an outperform vote.
Modular Medical currently has a consensus price target of $4.25, suggesting a potential upside of 136.10%. LENSAR has a consensus price target of $8.00, suggesting a potential upside of 111.64%. Given LENSAR's higher probable upside, equities analysts plainly believe Modular Medical is more favorable than LENSAR.
Modular Medical has a beta of 0.5, indicating that its share price is 50% less volatile than the S&P 500. Comparatively, LENSAR has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500.
27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 40.2% of LENSAR shares are owned by institutional investors. 32.3% of Modular Medical shares are owned by insiders. Comparatively, 66.0% of LENSAR shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Modular Medical has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.
Modular Medical has a net margin of 0.00% compared to Modular Medical's net margin of -27.57%. Modular Medical's return on equity of -36.53% beat LENSAR's return on equity.
In the previous week, LENSAR had 8 more articles in the media than Modular Medical. MarketBeat recorded 9 mentions for LENSAR and 1 mentions for Modular Medical. LENSAR's average media sentiment score of 0.93 beat Modular Medical's score of 0.69 indicating that Modular Medical is being referred to more favorably in the media.
Summary
Modular Medical beats LENSAR on 9 of the 16 factors compared between the two stocks.
Get LENSAR News Delivered to You Automatically
Sign up to receive the latest news and ratings for LNSR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LNSR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
